Beasley Allen lawyer Navan Ward, Jr., has been selected to serve as President-Elect of the American Association for Justice. The election was announced today at the organization’s annual convention. This will be Ward’s fifth consecutive year serving as an AAJ Officer and seventh consecutive year serving on the Executive Committee. The AAJ is dedicated to preserving the civil justice system and making sure that powerful special interests are held accountable when they engage in misconduct or negligence.
“It is an honor to continue serving such a great organization that remains committed to ensuring access to justice to everyone in our country,” Ward said. “This is a fundamental value in our nation and one that should never be taken for granted. The American Association for Justice stands ready to defend the justice system because consumers who have been injured through no fault of their own should have the same level of access to justice as even the most powerful corporations.”
Ward is the firm’s lead attorney on the metal-on-metal hip implant litigation and proton pump inhibitor (PPI) litigation, and practices from the Atlanta office. He serves on the Plaintiffs Steering Committee (PSC) for the DePuy “ASR” Hip Implant Recall Multi-District Litigation (MDL) and was appointed as co-lead counsel for the Plaintiffs Executive Committee (PEC) in the Biomet M2a Magnum Hip Implant Products Liability MDL. Ward has been instrumental in assisting with the verdicts and global settlements against major hip implant manufacturers, including Johnson & Johnson / DePuy for $4.057 billion, Howmedica Osteonics Corporation / Stryker for over $1 billion, and Biomet Corporation for more than $250 million, as well as additional confidential settlements involving other metal-on-metal and/or modular-neck hip components. Ward has also been appointed to the PEC for the PPI MDL.
Before his work on PPI and hip implant recall litigation, Ward was heavily involved with the hormone replacement therapy litigation, representing hundreds of women who were diagnosed with breast cancer as a result of ingesting these combination hormone medications. His trial team was responsible for obtaining a $72.6 million verdict for three hormone therapy clients that went to trial. Ward was also responsible for overseeing the Meridia pharmaceutical drug litigation, a medication that caused heart attacks and strokes, and was heavily involved with the Cox-2 (Vioxx, Celebrex and Bextra) pharmaceutical drug litigation. His practice has also handled personal injury and wrongful death cases including those involving nursing home abuse and neglect, as well as trucking crashes. Overall, Ward has obtained more than $360 million for the specific clients that he has represented in the various areas he has practiced.
For his efforts in representing clients, Beasley Allen awarded him as the firm’s Litigator of the Year in 2013 and Mass Torts Litigator of the Year in 2011 and 2014.
In 2017, Ward received the AAJ Minority Caucus Stalwart Award for his dedicated years of service to the Minority Caucus and the organization overall. It also awarded him the AAJ Distinguished Service Award in 2012 and 2015, along with its Wiedemann & Wysocki Award in 2014. Ward has been regularly selected to the Best Lawyers in America list, the Super Lawyers list and has been named to the LawDragon 500 Leading Plaintiff Consumer Lawyers, which is the 500 best attorneys across the nation in this category.
Ward previously served in other AAJ leadership positions including as a past chairman of the Minority Caucus, past chairman of the Diversity Committee and a member of the Board of Governors. He is a former Alabama State Bar delegate for the American Bar Association, past president of the Alabama Lawyers Association, the Alabama State Bar’s Young Lawyers Section, and the Montgomery County Association for Justice. Ward was a member of Leadership Montgomery’s Class XXI, a former chairman of the Father Walters Charity Golf Tournament, and a member of the Alabama Law Foundation Grant Committee.